Wellnex Life Limited reported unaudited revenue results for the first half of fiscal year of 2022. Revenue for the first half of FY22 was up18.5% up on the prior corresponding period (PCP) to $8.84 million (unaudited), with an additional $1.6 million in Purchase Orders received to be invoiced in the second half of 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 AUD | +12.50% |
|
+8.00% | +17.39% |
06-05 | Wellnex Life to Launch Medicinal Cannabis Product Range; Shares Fall 3% | MT |
05-24 | Wellnex Life Partners Chemist Warehouse to Reintroduce Pain Away in New Zealand | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.39% | 20.6M | |
+30.91% | 30.21B | |
-16.69% | 4.13B | |
+7.48% | 3.9B | |
-7.83% | 1.71B | |
-2.61% | 1.61B | |
-13.68% | 1.24B | |
-22.59% | 1.05B | |
-36.76% | 798M | |
+2.77% | 652M |
- Stock Market
- Equities
- WNX Stock
- News Wellnex Life Limited
- Wellnex Life Limited Reports Unaudited Revenue Results for the First Half of Fiscal Year of 2022